Alpha Tau Medical
DRTS
20 hedge funds and large institutions have $4.11M invested in Alpha Tau Medical in 2023 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.
250% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 2
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
120% more capital invested
Capital invested by funds: $1.87M → $4.11M (+$2.24M)
25% more funds holding
Funds holding: 16 → 20 (+4)
0.43% more ownership
Funds ownership: 0.94% → 1.37% (+0.43%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
+$1.12M |
| 2 |
CCP
Corbin Capital Partners
New York
|
+$932K |
| 3 |
ACM
Atalaya Capital Management
New York
|
+$264K |
| 4 |
GSC
Grey Street Capital
Chicago,
Illinois
|
+$83.6K |
| 5 |
Morgan Stanley
New York
|
+$77.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.04M |
| 2 |
JP Morgan Chase
New York
|
-$69.5K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$3.71K |
DRTS Hedge Fund Activity: Q2 2023 in Review
20 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Alpha Tau Medical (DRTS) for Q2 2023, worth a combined $4.11M — up 120% from $1.87M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new DRTS positions and 2 closed out — a net gain of 5 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Citigroup, adding an estimated $1.12M. The largest seller was Fidelity Investments, exiting entirely with an estimated $1.04M sold.
- 20 institutional investors held Alpha Tau Medical (DRTS) as of Q2 2023, up from 16 in Q1 2023.
- Funds reported $4.11M of Alpha Tau Medical stock for Q2 2023, up 120% quarter-over-quarter.
- 7 funds opened new Alpha Tau Medical positions in Q2 2023 and 2 closed out, a net change of +5 holders.
- The largest Alpha Tau Medical buyer in Q2 2023 was Citigroup, an estimated $1.12M added.
- The largest Alpha Tau Medical seller in Q2 2023 was Fidelity Investments, an estimated $1.04M sold.
Based on aggregated 13F filings for Q2 2023.